[Fast control of manic or mixed episodes. Atypical neuroleptics for bipolar patients].
D000208:Acute Disease; D018692:Antimanic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001569:Benzodiazepines; D001714:Bipolar Disorder / Q000175:diagnosis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D018492:Dopamine Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006220:Haloperidol / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007554:Isotopes; D008094:Lithium / Q000008:administration & dosage / Q000627:therapeutic use; D000077152:Olanzapine; D010890:Pirenzepine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors; D014635:Valproic Acid / Q000008:administration & dosage / Q000627:therapeutic use
D018692:Antimanic Agents; D014150:Antipsychotic Agents; D001569:Benzodiazepines; D018492:Dopamine Antagonists; D006220:Haloperidol; D007554:Isotopes; D008094:Lithium; D000077152:Olanzapine; D010890:Pirenzepine; D017367:Selective Serotonin Reuptake Inhibitors; D014635:Valproic Acid